Ching‐Chi Lee
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 42
- Sepsis Diagnosis and Treatment 13
- Pneumonia and Respiratory Infections 7
-
- Clostridium difficile and Clostridium perfringens research 12
- Co-authors
- Wen‐Chien Ko (94 shared papers)Nan–Yao Lee (45 shared papers)Chia‐Ming Chang (30 shared papers)Ming‐Yuan Hong (30 shared papers)Po‐Lin Chen (31 shared papers)Chung-Hsun Lee (24 shared papers)Chih‐Chia Hsieh (32 shared papers)Ming-Chi Li (13 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (22 papers)The American Journal of Emergency Medicine (14 papers)Diagnostic Microbiology and Infectious Disease (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)Antibiotics (6 papers)
- Partner nations
- TaiwanUnited StatesNew Zealand
In The Last Decade
Ching‐Chi Lee
113 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 124
- Applied Microbiology and Biotechnology 205
- Molecular Medicine 503
- Endocrinology 206
- Clinical Biochemistry 254
- Infectious Diseases 457
Countries citing papers authored by Ching‐Chi Lee
This map shows the geographic impact of Ching‐Chi Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chi Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chi Lee more than expected).
Fields of papers citing papers by Ching‐Chi Lee
This network shows the impact of papers produced by Ching‐Chi Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chi Lee. The network helps show where Ching‐Chi Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Chi Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 149 | |
| 2 | 2012 | 108 | |
| 3 | 2017 | 81 | |
| 4 | 2022 | 70 | |
| 5 | 2021 | 66 | |
| 6 | 2015 | 61 | |
| 7 | 2010 | 53 | |
| 8 | 2008 | 51 | |
| 9 | 2011 | 51 | |
| 10 | 2011 | 51 | |
| 11 | 2014 | 50 | |
| 12 | 2010 | 45 | |
| 13 | 2010 | 43 | |
| 14 | 2014 | 42 | |
| 15 | 2012 | 41 | |
| 16 | 2016 | 34 | |
| 17 | 2013 | 33 | |
| 18 | 2019 | 33 | |
| 19 | 2012 | 33 | |
| 20 | 2017 | 33 |
About Ching‐Chi Lee
Ching‐Chi Lee is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Endocrinology, having authored 119 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Bacterial Identification and Susceptibility Testing (15 papers), Sepsis Diagnosis and Treatment (13 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Use and Resistance (9 papers), Pneumonia and Respiratory Infections (7 papers) and Nosocomial Infections in ICU (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (205 citations), Molecular Medicine (503 citations), Endocrinology (206 citations), Clinical Biochemistry (254 citations) and Infectious Diseases (457 citations). Ching‐Chi Lee has collaborated with scholars based in Taiwan, United States and New Zealand. Frequent co-authors include Wen‐Chien Ko, Nan–Yao Lee, Chia‐Ming Chang, Ming‐Yuan Hong, Po‐Lin Chen, Chung-Hsun Lee, Chih‐Chia Hsieh, Ming-Chi Li, Yuan‐Pin Hung and Hsin–Chun Lee. Their work appears in journals such as Journal of Microbiology Immunology and Infection, The American Journal of Emergency Medicine, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.